Venter Pharma SL

About:

Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.

Website: http://www.venterpharma.com/

Top Investors: EASME - EU Executive Agency for SMEs, Grupo Ferrer Internacional, Clave Mayor

Description:

Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals. It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively. Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose

Total Funding Amount:

3.55M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Alcobendas, Madrid, Spain

Founded Date:

2003-01-01

Contact Email:

info(AT)venterpharma.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2014-03-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai